SEC Form 4 · accession 0001104659-16-109969
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philippe Brianceau
Officer — Chief Veterinary Officer
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 7:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.58 | Apr 1, 2016 | A | 20,000 | A | — | Apr 1, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Stock Incentive Plan.
- F2The option becomes exercisable as to 25% of the shares on November 22, 2016, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter.